A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

Summary

This study will evaluate whether teriparatide is superior to the active comparator in the change from baseline of lumbar spine BMD (bone mineral density) in men and postmenopausal women with low bone mass and a recent pertrochanteric hip fracture.

Timeline

Start

2009-04

Primary completion

2015-08

Completion

2015-08

Outcome

Met primary endpoint

registry analysis (unspecified test); Teriparatide vs Risedronate; p <.0001; LS Mean 0.040 (95% CI 0.025 to 0.055); Mixed Models Analysis NCT00887354 ↗

Drugs

Indications